Tradestie Institutional Equity Comparison Engine
EKSO vs AACB โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AACB Overall Edge
AACB Captures Institutional Edge (2โ1 Pillars ยท 8โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AACB (AACB) driven by superior Valuation, Growth & Margin while EKSO counters with relative strength in Momentum & Technical. Fundamentally, EKSO trades at N/M Forward P/E with -119.7% operating margin (-38.3% YoY revenue) versus AACB at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, EKSO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AACB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
AACB
EKSO N/M vs AACB N/M Fwd P/E
Growth & Margin Winner
AACB
Op Margin -119.7% vs 0.0% ยท YoY -38.3% vs +0.0%
Momentum & Technical Winner
EKSO
1Y +62.6% vs +5.5% ยท 52W Pos 87% vs 98%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
EKSO
NASDAQ
Ekso Bionics Holdings, Inc. Common Stock
General Industrial Machinery & Equipment, Nec
$11.80
+0.08% 1D
Market Cap
$42.0M
1M Return
+25.53%
1Y Return
+62.6%
Forward P/E
N/M
Unified AI Score
58.1 / 100
HOLD
Tech 60.0
Fund 54.0
Flow 50.0
Mom 50.0
AACB
US Equity
AACB
Institutional Equity
$10.59
+0.09% 1D
Market Cap
$292.8M
1M Return
+0.86%
1Y Return
+5.48%
Forward P/E
N/M
Unified AI Score
55.3 / 100
HOLD
Tech 44.0
Fund 52.0
Flow 50.0
Mom 70.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
EKSO +62.6%
AACB +5.48%
Spread: +4113.81 pp (EKSO Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
EKSO TTM Op. Margin: -119.7%
AACB TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EKSO vs AACB. Trailing 12-month operating profitability (EKSO -119.7% vs AACB 0.0%) and valuation multiples (EKSO N/M vs AACB N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | EKSO | AACB | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $42.0M | $292.8M | Larger Scale | AACB |
| Trailing P/E Ratio Valuation | N/M | 62.2x | Lower Multiple | AACB |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -38.3% | +0.0% | Higher Growth | AACB |
| Operating Margin (TTM) Profitability | -119.7% | 0.0% | Higher Margin | AACB |
| Net Profit Margin Profitability | -91.4% | 0.0% | Higher Margin | AACB |
| Return on Equity (ROE) Capital Efficiency | -107.6% | 0.0% | Higher ROE | AACB |
| 52-Week Range Position Momentum | 87% ($0โ$14) | 98% ($10โ$11) | Stronger Trend | AACB |
| Beta / 30D Volatility Risk Regime | 2.16ฮฒ ยท 76% Vol | 0.02ฮฒ ยท 3% Vol | Lower Realized Risk | AACB |
| Unified Institutional Score Composite Signal | 58.1 / 100 (HOLD) | 55.3 / 100 (HOLD) | Higher Composite | EKSO |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full EKSO vs AACB Buy Guide
EKSO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
AACB
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither EKSO nor AACB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.